Can-Fite Biopharma Ltd ADR (CANF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 2,032 | 3,820 | 789 | 170 | 165 |
| Gross Profit | 2,032 | 3,820 | 789 | 170 | 165 |
| Operating Expenses | 14,039 | 9,234 | 7,974 | 8,807 | 6,583 |
| Operating Income | -12,007 | -5,414 | -7,185 | -8,637 | -6,418 |
| Interest Expense | 618 | 1,204 | 621 | 178 | 564 |
| Other Income | 0 | 51 | 1,402 | 1,820 | 1,920 |
| Pre-tax Income | -12,625 | -6,567 | -6,404 | -6,995 | -5,062 |
| Income Tax | N/A | 4 | 29 | 29 | 4 |
| Net Income Continuous | -12,625 | -6,571 | -6,433 | -7,024 | -5,066 |
| Minority Interests | N/A | N/A | -94 | -124 | -267 |
| Net Income | $-12,625 | $-6,571 | $-6,339 | $-6,900 | $-4,799 |
| EPS Basic Total Ops | -42.00 | -51.00 | -56.97 | -74.96 | -62.97 |
| EPS Basic Continuous Ops | -44.09 | -50.67 | -59.31 | -74.80 | -66.47 |
| EPS Diluted Total Ops | -42.00 | -51.00 | -56.97 | -74.96 | -62.97 |
| EPS Diluted Continuous Ops | -44.09 | -50.67 | -59.31 | -74.80 | -66.47 |
| EPS Diluted Before Non-Recurring Items | -33.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-11,993 | $-5,400 | $-7,166 | $-8,619 | $-6,402 |